Matrix Metalloproteinase 17 [matrixová metaloproteinasa 17]
- Terms
-
matrix metaloproteináza 17
matrixová metaloproteináza 17
matrixová metaloproteináza membránového typu 4
metaloproteinasa MMP-17
metaloproteinasa MMP17
metaloproteináza MMP-17
metaloproteináza MMP17
MT-MMP-4
MT4-MMP
-
Membrane-Type 4 Matrix Metalloproteinase
Membrane-Type Matrix Metalloproteinase 4
MMP-17 Metalloproteinase
MMP17 Metalloproteinase
MT-MMP-4
MT4-Matrix Metalloproteinase
MT4-MMP
A membrane-type metalloproteinase that is associated with the CELL MEMBRANE via a GLYCOSYL-PHOSPHATIDYLINOSITOL linkage. It is synthesized as an inactive zymogen that is activated by the action of PROPROTEIN CONVERTASES such as FURIN.
- DUI
- D053515 MeSH Browser
- CUI
- M0485717
- History note
- 2007(2005)
- Public note
- 2007; MATRIX METALLOPROTEINASE 17 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 1994-2005
Combination
- antagonists & inhibitors
- Matrix Metalloproteinase Inhibitors
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AN
- analysis
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine